ACACB and cardiac hypertrophy: Cardiac-specific deletion of acetyl-CoA carboxylase 2, which induced a significant reduction of cardiac malonyl-CoA levels and led to a maintenance of fatty acid oxidation, has previously been shown to attenuate cardiac hypertrophy and to reduce cardiac fibrosis in a model of pressure overload [33].